Skip to content Skip to navigation

Weill Cornell, New York Presbyterian Launch Individualized Medicine Hub

January 31, 2013
by Rajiv Leventhal
| Reprints

New York-based Weill Cornell Medical College and NewYork-Presbyterian Hospital have partnered to create the Institute for Precision Medicine, a new medicine research hub that will offer targeted, individualized treatment based on each patient's genetic profile.

The Institute for Precision Medicine will be led by Dr. Mark Rubin, a renowned pathologist and prostate cancer expert who uses whole genomic sequencing in his laboratory to investigate DNA mutations that lead to disease, particularly prostate cancer.

The institute's new genomic research discoveries will help develop novel, personalized medical therapies to be tested in innovative clinical trials, while also building a comprehensive biobank to improve research and patient care. "This institute will revolutionize the way we treat disease, linking cutting-edge research and next-generation sequencing in the laboratory to the patient's bedside," Rubin said in a statement. "We will use advanced technology and the collective wealth of knowledge from our clinicians, basic scientists, pathologists, molecular biologists and computational biologists to pinpoint the molecular underpinnings of disease -- information that will spur the discovery of novel treatments and therapies. It's an exciting time to be involved in precision medicine and I look forward to advancing this game-changing field of medicine."

 Rubin and his team seek to replace the traditional one-size-fits-all medicine paradigm with one that focuses on targeted, individualized patient care using a patient's own genetic profile and medical history. Physician-scientists at the institute will seek to precisely identify the genetic influencers of a patient's specific illness—such as cancer, cardiovascular disease, neurodegenerative disease and others—and use this genetic information to design a more-effective course of treatment that targets those specific contributing factors. Also, genomic analyses of tumor tissue will enable researchers to help patients with advanced disease and no current treatment options, as well as to isolate the causes of drug resistance in patients who stop responding to treatments, redirecting them to more successful therapies.

Preventive precision medicine will also be a key initiative at the institute, allowing physician-scientists to help identify a patient's risk of diseases and take necessary steps to aid in its prevention through medical treatment and/or lifestyle modification. In addition, the Institute for Precision Medicine will leverage an arsenal of innovative genomic sequencing, biobanking and bioinformatics technology to transform the existing paradigm for diagnosing and treating patients. 

 

Topics

News

AI-Powered Wearables Market to Grow 376 Percent in 2017

The market segment for artificial intelligence (AI)-powered wearables will grow 376 percent annually in 2017 to reach 60 million units, according to a new Counterpoint Technology Market Research report.

Study: Cybersecurity Budgets, Staff Growing, but Many Organizations Still Lagging

Cybersecurity budgets are growing and healthcare organizations are allocating more employees to IT security compared to a year ago, however, despite the progress, significant gaps remain, according to a study from HIMSS Analytics and Symantec released last week during the HIMSS17 conference.

Aetna Joins CMS’ CPC+ Primary Care Initiative in Pennsylvania

Aetna announced last week that it would collaborate with other health plans in its region and local primary care practices as part of the federal government’s Comprehensive Primary Care + (CPC+) initiative.

Lenovo Health and Orbita Launch Voice-Enabled Home Health Assistant Technology

North Carolina-based health IT company Lenovo Health and Orbita, a Boston-based connected home healthcare company, launched a virtual home care solution and showcased the technology at HIMSS17 in Orlando.

Phase 2 Winners Chosen in ‘Move Health Data Forward’ Challenge

The Office of the National Coordinator for Health Information Technology has announced five winners in Phase 2 of the “Move Health Data Forward” Challenge, a contest to develop solutions to help with the flow of health information.

National Association for Trusted Exchange Unveils FHIR-Based Solution for Data Sharing

At the HIMSS17 conference in Orlando on Monday, The National Association for Trusted Exchange (NATE) unveiled NATE’s Blue Button Directory (NBBD) and is demonstrating it as part of the Federal Health Architecture’s demonstrations in the HIMSS17 Interoperability Showcase.